Two Sigma Securities »

Bolt Biotherapeutics shares owned by Two Sigma Securities

Quarter-by-quarter ownership of Bolt Biotherapeutics (BOLT) shares owned by Two Sigma Securities from 13F filings

Historical chart of Two Sigma Securities investment in Bolt Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bolt Biotherapeutics held by Two Sigma Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bolt Biotherapeutics by Two Sigma Securities

Quarter filed Position value Share count Share price at filing
2023-12-31 $72k 64k 1.12

More positions owned by Two Sigma Securities

Apple (AAPL)
Microsoft Corporation Call Option (MSFT)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Tesla Motors (TSLA)
Meta Platforms Cl A Call Option (META)
Amazon (AMZN)
Netflix (NFLX)
Advanced Micro Devices Call Option (AMD)
Boeing Company Call Option (BA)
Alphabet Cap Stk Cl A (GOOGL)
Visa Com Cl A (V)
Johnson & Johnson Call Option (JNJ)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Broadcom Call Option (AVGO)

View all positions for Two Sigma Securities

Top funds holding Bolt Biotherapeutics

Tang Capital Management
Vivo Capital
Citadel Advisors
Newtyn Management
OrbiMed Advisors
Samsara BioCapital
Vanguard Group
Board of Trustees of The Leland Stanford Junior University
Acuitas Investments
Marquette Asset Management
Squarepoint Ops
Two Sigma Securities
Jane Street
Millennium Management
UBS Group

View all funds holding Bolt Biotherapeutics